Archive for category: Research
Watch the MINT Clinical Trial for Myositis Patients with Interstitial Lung Disease Webinar

Watch the MINT Clinical Trial for Myositis Patients with Interstitial Lung Disease webinar with Dr. Rohit Aggarwal. This clinical...
Stephen Moore, a Neuroscientist living with Dermatomyositis joined MSU's Patient-Centered Research Team. His passion lies in advancing research efforts...
Co-authors of “Pain profile and opioid medication use in patients with idiopathic inflammatory myopathies”, published in Rheumatology discuss the...
MSU is attending the 2022 Global Conference on Myositis in Prague and will be represented in two (2) scientific...
Kezar Announces Topline Results from the PRESIDIO Trial of Zetomipzomib for the Treatment of Dermatomyositis and Polymyositis
Pain profile and opioid medication use in patients with idiopathic inflammatory myopathies

We are excited to announce our first publication, “Pain profile and opioid medication use in patients with idiopathic inflammatory...
Watch the recording with Alexion Pharmaceuticals to learn about the Flex Study to evaluate the safety and efficacy of...
Myositis patients and caregivers are invited to participate in a survey to help us understand how myositis impacts certain...
Intravenous Immune Globulin (IVIg) – A newly approved therapeutic option for the treatment of adult dermatomyositis

Watch to learn about Octapharma’s IVIg therapy and the results of the landmark Progress in Dermatomyositis (ProDERM) study. The...
Watch Poor Long-term Clinical Outcomes and Health-Related Quality of Life in Dermatomyositis and Polymyositis

Dermatomyositis (DM) and polymyositis (PM) are rare autoimmune inflammatory myopathies characterized by muscle weakness and multiple extra-muscular manifestations that...
Pain Presentation at Annual Carrell-Krusen Neuromuscular Symposium

Excited to announce that our study “Pain profile and opioid medication use in myositis “ will be presented at...
MSU to host the first FDA Listening Session for Adult Dermatomyositis!

MSU is hosting the first FDA Listening Session on Adult Dermatomyositis on April 26, 2022. We hope the FDA will come...
Plasma Services Group (PSG) provides an update on what your samples are being used for and how important it...
AllStripes & MSU: You can accelerate drug development in Dermatomyositis!

AllStripes was honored to host this webinar with the Myositis Support and Understanding Association to discuss our current and...
Myositis Support & Understanding and AllStripes Partner for New Dermatomyositis Research

Myositis Support & Understanding and AllStripes are partnering to create a database that will enable new Dermatomyositis research projects!...
Corbus Pharmaceuticals Announces Topline Results from DETERMINE Phase 3 Study of Lenabasum for Treatment of Dermatomyositis

Corbus releases topline results for the phase 3 study of lenabasum in dermatomyositis. While it didn't meet the primary...
AllStripes provides an update on the inclusion body myositis (IBM) research program and the video includes a step-by-step walkthrough...